Matches in Wikidata for { <http://www.wikidata.org/entity/Q90934177> ?p ?o ?g. }
Showing items 1 to 64 of
64
with 100 items per page.
- Q90934177 description "2018 թվականին հրատարակված գիտական հոդված" @default.
- Q90934177 description "article scientifique (publié 2018)" @default.
- Q90934177 description "articolo scientifico (pubblicato il 2018)" @default.
- Q90934177 description "artigo científico (publicado na 2018)" @default.
- Q90934177 description "artikull shkencor i botuar më 01 janar 2018" @default.
- Q90934177 description "artículo científico publicado en 2018" @default.
- Q90934177 description "artículu científicu espublizáu en xineru de 2018" @default.
- Q90934177 description "im Januar 2018 veröffentlichter wissenschaftlicher Artikel" @default.
- Q90934177 description "scientific article published on 01 January 2018" @default.
- Q90934177 description "wetenschappelijk artikel" @default.
- Q90934177 description "наукова стаття, опублікована 1 січня 2018" @default.
- Q90934177 description "научна статия" @default.
- Q90934177 name "Low-dose staurosporine selectively reverses BCR-ABL-independent IM resistance through PKC-α-mediated G2/M phase arrest in chronic myeloid leukaemia" @default.
- Q90934177 name "Low-dose staurosporine selectively reverses BCR-ABL-independent IM resistance through PKC-α-mediated G2/M phase arrest in chronic myeloid leukaemia" @default.
- Q90934177 name "Low-dose staurosporine selectively reverses BCR-ABL-independent IM resistance through PKC-α-mediated G2/M phase arrest in chronic myeloid leukaemia" @default.
- Q90934177 type Item @default.
- Q90934177 label "Low-dose staurosporine selectively reverses BCR-ABL-independent IM resistance through PKC-α-mediated G2/M phase arrest in chronic myeloid leukaemia" @default.
- Q90934177 label "Low-dose staurosporine selectively reverses BCR-ABL-independent IM resistance through PKC-α-mediated G2/M phase arrest in chronic myeloid leukaemia" @default.
- Q90934177 label "Low-dose staurosporine selectively reverses BCR-ABL-independent IM resistance through PKC-α-mediated G2/M phase arrest in chronic myeloid leukaemia" @default.
- Q90934177 prefLabel "Low-dose staurosporine selectively reverses BCR-ABL-independent IM resistance through PKC-α-mediated G2/M phase arrest in chronic myeloid leukaemia" @default.
- Q90934177 prefLabel "Low-dose staurosporine selectively reverses BCR-ABL-independent IM resistance through PKC-α-mediated G2/M phase arrest in chronic myeloid leukaemia" @default.
- Q90934177 prefLabel "Low-dose staurosporine selectively reverses BCR-ABL-independent IM resistance through PKC-α-mediated G2/M phase arrest in chronic myeloid leukaemia" @default.
- Q90934177 P1433 Q90934177-9475B311-7BB6-47D9-B64E-D014CF96965E @default.
- Q90934177 P1476 Q90934177-B7746A6A-43F9-4E6D-8BB9-7015847C46F8 @default.
- Q90934177 P2093 Q90934177-2112DEED-814A-46CD-BEB0-873BE6B9E0EC @default.
- Q90934177 P2093 Q90934177-5BABD382-0778-4262-BC4C-064FCD6547B1 @default.
- Q90934177 P2093 Q90934177-60D4796C-2083-4A13-9A5E-FE3526AE1911 @default.
- Q90934177 P2093 Q90934177-6EB69F53-338A-4F35-A13F-C0714B4E30AF @default.
- Q90934177 P2093 Q90934177-7DD9C368-6C30-4FD3-89A6-55BF234EA9AF @default.
- Q90934177 P2093 Q90934177-814EE984-5308-494E-92A5-D8DF99AC9ED7 @default.
- Q90934177 P2093 Q90934177-84E142CA-DEB9-4C62-8019-D3FBC0E1CFE8 @default.
- Q90934177 P2093 Q90934177-8A765104-3176-474C-BF54-80CA639D6DB5 @default.
- Q90934177 P2093 Q90934177-BB8D4A5C-95AE-476D-BA5B-12803F90CB90 @default.
- Q90934177 P2093 Q90934177-BE2FA568-1348-4F17-8F0F-1A672789EC66 @default.
- Q90934177 P2093 Q90934177-D78E2F82-8E5C-42BF-84BF-32C324A22ECC @default.
- Q90934177 P304 Q90934177-59B57036-46DD-4CE1-8158-11646053ECB0 @default.
- Q90934177 P31 Q90934177-49EC2E54-7B1D-4B73-B6E4-6A31F86A060C @default.
- Q90934177 P356 Q90934177-B4F94592-9485-41E6-B240-43EDCA5B7356 @default.
- Q90934177 P433 Q90934177-B433EA59-3972-4E59-AB93-FB45ABA13C09 @default.
- Q90934177 P478 Q90934177-F3392F43-2D40-4F75-9837-A0FB2C3C787E @default.
- Q90934177 P577 Q90934177-597433F9-E7A4-4D73-A9EA-3F0868E0A1F3 @default.
- Q90934177 P698 Q90934177-C22F91AF-B398-443A-B44E-EB673E3AE9E2 @default.
- Q90934177 P356 21691401.2018.1490310 @default.
- Q90934177 P698 30618318 @default.
- Q90934177 P1433 Q27724536 @default.
- Q90934177 P1476 "Low-dose staurosporine selectively reverses BCR-ABL-independent IM resistance through PKC-α-mediated G2/M phase arrest in chronic myeloid leukaemia" @default.
- Q90934177 P2093 "Dan Ma" @default.
- Q90934177 P2093 "Danna Wei" @default.
- Q90934177 P2093 "Jishi Wang" @default.
- Q90934177 P2093 "Kunling Yu" @default.
- Q90934177 P2093 "Ping Wang" @default.
- Q90934177 P2093 "Qin Fang" @default.
- Q90934177 P2093 "Tingting Lu" @default.
- Q90934177 P2093 "Yaming Zhang" @default.
- Q90934177 P2093 "Zhen Zhou" @default.
- Q90934177 P2093 "Zhengchang He" @default.
- Q90934177 P2093 "Zhengyu Yu" @default.
- Q90934177 P304 "S208-S216" @default.
- Q90934177 P31 Q13442814 @default.
- Q90934177 P356 "10.1080/21691401.2018.1490310" @default.
- Q90934177 P433 "sup3" @default.
- Q90934177 P478 "46" @default.
- Q90934177 P577 "2018-01-01T00:00:00Z" @default.
- Q90934177 P698 "30618318" @default.